Cancer Research Targets  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hosch, S.
Right arrow Articles by Pantel, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hosch, S.
Right arrow Articles by Pantel, K.
[Cancer Research 60, 6836-6840, December 15, 2000]
© 2000 American Association for Cancer Research


Advances in Brief

Malignant Potential and Cytogenetic Characteristics of Occult Disseminated Tumor Cells in Esophageal Cancer1

Stefan Hosch2, Jürgen Kraus2, Peter Scheunemann, Jakob Robert Izbicki, Claus Schneider, Udo Schumacher, Klaus Witter, Michael R. Speicher and Klaus Pantel3

Chirurgische Klinik und Poliklinik [S. H., P. S., J. R. I., C. S.] and Molekulare Onkologie der Universitäts-Frauenklinik [K. P.], and Institut für Anatomie [U. S.], Universitätsklinikum Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany; Institut für Anthropologie und Humangenetik [J. K., M. R. S.] and Institut für Immunologie [K. W.], Ludwig-Maximilians-Universität München, Goethestrasse 31, D-80336 München, Germany

Although micrometastatic cancer cells in lymph nodes can be detected by monoclonal antibodies against epithelial or tumor-associated antigens, it remains unclear whether these cells are precursors of overt metastases or shedded tumor cells with a limited life span. Here we used esophageal cancer as a model to evaluate the prognostic significance and biological characteristics of such micrometastases. In lymph nodes classified as tumor free by conventional histopathological staging, tumor cells were identified with monoclonal antibody Ber-EP4 in 89 of 126 patients (71%) with completely resected (R0) esophageal carcinomas. Multivariate survival analysis underlined the strong and independent prognostic significance of Ber-EP4-positive cells in "node-negative" (pN0) patients. To assess the biology of Ber-EP4-positive cells, we established tumor cell lines from an immunohistochemically positive lymph node and the autologous primary tumor. p53 mutational analysis and multiplex-fluorescence in situ hybridization revealed common aberrations shared between both cell lines, whereas an insertion of chromosome 13 material in the short arm of chromosome 1 was only observed in micrometastatic cells. The tumorigenicity and metastatic potential of both cell lines were demonstrated in severe combined immunodeficient mice. In conclusion, our data provide first direct evidence for the malignant potential of micrometastatic cancer cells.




This article has been cited by other articles:


Home page
Cancer Res.Home page
C. A. Klein and N. H. Stoecklein
Lessons from an Aggressive Cancer: Evolutionary Dynamics in Esophageal Carcinoma
Cancer Res., July 1, 2009; 69(13): 5285 - 5288.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. Kan, Y. Shimada, F. Sato, T. Ito, K. Kondo, G. Watanabe, M. Maeda, S. Yamasaki, S. J. Meltzer, and M. Imamura
Prediction of Lymph Node Metastasis with Use of Artificial Neural Networks Based on Gene Expression Profiles in Esophageal Squamous Cell Carcinoma
Ann. Surg. Oncol., December 1, 2004; 11(12): 1070 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
X. Jiao, A. Eslami, O. Ioffe, K. F. Kwong, M. Henry, Q. Zeng, Y. Refaely, W. Burrows, Z. Gamliel, and M. J. Krasna
Immunohistochemistry analysis of micrometastasis in pretreatment lymph nodes from patients with esophageal cancer
Ann. Thorac. Surg., October 1, 2003; 76(4): 996 - 1000.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Hegewisch-Becker, K. Braun, M. Otte, A. Corovic, D. Atanackovic, A. Nierhaus, D. K. Hossfeld, and K. Pantel
Effects of Whole Body Hyperthermia (41.8{degrees}C) on the Frequency of Tumor Cells in the Peripheral Blood of Patients with Advanced Malignancies
Clin. Cancer Res., June 1, 2003; 9(6): 2079 - 2084.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
A. J. McGeorge, B. J. Vote, D. A. Elliot, and P. J. Polkinghorne
Papillary Adenocarcinoma of the Iris Transmitted by Corneal Transplantation
Arch Ophthalmol, October 1, 2002; 120(10): 1379 - 1383.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
X. Jiao and M. J. Krasna
Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology
Ann. Thorac. Surg., July 1, 2002; 74(1): 278 - 284.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. H. Stoecklein, A. Erbersdobler, O. Schmidt-Kittler, J. Diebold, J. A. Schardt, J. R. Izbicki, and C. A. Klein
SCOMP Is Superior to Degenerated Oligonucleotide Primed-Polymerase Chain Reaction for Global Amplification of Minute Amounts of DNA from Microdissected Archival Tissue Samples
Am. J. Pathol., July 1, 2002; 161(1): 43 - 51.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
B. Passlick, B. Kubuschock, W. Sienel, O. Thetter, K. Pantel, and J.R. Izbicki
Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases -- results of a preliminary study
Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 520 - 526.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. C. Redmond, J. H. Wang, K. K. Austin, N. Relihan, G. McGreal, W. O. Kirwan, D. Richardson, J. Kelly, H. P. Redmond, S. Braun, et al.
Is Immunohistochemical Analysis an Appropriate Diagnostic Technique for Bone Marrow Micrometastases?
J. Clin. Oncol., August 1, 2001; 19(15): 3589 - 3592.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.